𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of a physical therapy program in patients with Parkinson’s disease: A randomized controlled trial

✍ Scribed by Terry Ellis; Cees J. de Goede; Robert G. Feldman; Erik C. Wolters; Gert Kwakkel; Robert C. Wagenaar

Book ID
116234536
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
136 KB
Volume
86
Category
Article
ISSN
1532-821X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot randomized controlled trial of s
A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers
✍ Iracema Leroi; Peter Baker; Pam Kehoe; Emily Daniel; E Jane Byrne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract ## Objective By means of a controlled trial, to investigate the efficacy, tolerability and feasibility of a multi‐component sleep therapy intervention versus basic sleep hygiene education in PD patients with sleep disturbances and their live‐in carers. ## Methods Patient‐carer dyads

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Randomized controlled trial of memantine
Randomized controlled trial of memantine in dementia associated with Parkinson's disease
✍ Iracema Leroi; Ross Overshott; E. Jane Byrne; Emily Daniel; Alistair Burns 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

## Abstract The objective of this study is to investigate the safety and tolerability of memantine, a glutamatergic modulator, in patients suffering from dementia associated with Parkinson's disease (PDD), an increasingly common complication of PD. This was a 22‐week trial of 25 participants with a

A controlled trial of piracetam in intel
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
✍ Mary Sano; Yaakov Stern; Karen Marder; Richard Mayeux 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract Twenty patients with Parkinson's disease and marked intellectual impairment or dementia participated in a double‐blind placebo controlled trial of the nootropic, piracetam. A standardized neurological examination, a neuropsychological test battery, and a functional scale, The Sickness I